Activation of Lipoprotein Lipase by Glucose-dependent Insulinotropic Polypeptide in Adipocytes
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Glucose-dependent insulinotropic polypeptide (GIP) has been mainly studied because of its glucose-dependent insulinotropic action and its ability to regulate beta-cell proliferation and survival. Considerably less is known about the effects of GIP on fat metabolism, and the present study was directed at identifying the mechanisms underlying its stimulatory action on lipoprotein lipase (LPL). In differentiated 3T3-L1 adipocytes, GIP, in the presence of insulin, increased LPL activity and triglyceride accumulation through a pathway involving increased phosphorylation of protein kinase B (PKB) and reductions in phosphorylated LKB1 and AMP-activated protein kinase (AMPK). Knockdown of AMPK using RNA interference and application of the AMPK inhibitor, Compound C, supported this conclusion. In contrast, the other major incretin hormone, glucagon-like peptide-1, exhibited no significant effects on LPL activity or PKB, LKB1, or AMPK phosphorylation. Cultured subcutaneous human adipocytes showed similar responses to GIP but with greater sensitivity. Chronic elevation of circulating GIP levels in the Vancouver diabetic fatty Zucker rat in vivo resulted in increased LPL activity and elevated triglyceride accumulation in epididymal fat tissue, combined with a modulation of PKB, LKB1, and AMPK phosphorylation similar to that observed in vitro. This appears to be the first demonstration of a GIP-stimulated signal transduction pathway involved in increasing fat storage in adipocytes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, treatment of diet-induced obese mice with a GCGR agonist revealed that glucagon-stimulated energy expenditure and weight loss can also be driven by hepatic amino acid catabolism, and thus a systemic response to hypoaminoacidemia74”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [74]
In the citing paper
“However, based on the lipogenetic properties205, 206, 207 of GIP, insufficient insulin-potentiating effects in T2DM patients220, 336 and a possible worsening effect by GIP,337, 338 the focus is on GLP-1 analogues/receptor agonists for T2DM treatment.”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [207]
In the citing paper
“GIP promotes lipogenesis and lipid deposition under conditions of hyperinsulinema [34–36] while stimulating lipolysis and fatty acid oxidation under conditions of normo- or hypoinsulinemia [37–39].”
From Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes (2024) · cites this paper as [34]
Citations
Cites
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Mechanism of activation of protein kinase B by insulin and IGF-1.
Alessi, D. R., Andjelkovic, M., Caudwell, B., Cron, P., Morrice, N., Cohen, P., & Hemmings, B. A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01045.x · Cited by 3,004
LKB1 is the upstream kinase in the AMP-activated protein kinase cascade
Woods, A., Johnstone, S. R., Dickerson, K., Leiper, F. C., Fryer, L. G. D., Neumann, D., Schlattner, U., Wallimann, T., Carlson, M., & Carling, D. (2003) · Current Biology · doi:10.1016/j.cub.2003.10.031 · Cited by 1,650
The AMP‐Activated Protein Kinase: Fuel Gauge of the Mammalian Cell?
Hardie, D. G., & Carling, D. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00259.x · Cited by 1,317
The AMP-activated protein kinase cascade – a unifying system for energy control
Carling, D. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.11.005 · Cited by 1,112
Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis
Goldberg, I. J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37569-6 · Cited by 1,010
Ram�rez-Zacar�as, J. L., Castro-Mu�ozledo, F., & Kuri-Harcuch, W. (1992) · Histochemistry · doi:10.1007/bf00316069 · Cited by 1,008
Inhibition of gastric inhibitory polypeptide signaling prevents obesity
Miyawaki, K., Yamada, Y., Ban, N., Ihara, Y., Tsukiyama, K., Zhou, H., Fujimoto, S., Oku, A., Tsuda, K., Toyokuni, S., et al. (2002) · Nature Medicine · doi:10.1038/nm727 · Cited by 963
AMP-Activated Protein Kinase – Development of the Energy Sensor Concept
Hardie, D. G., Hawley, S. A., & Scott, J. W. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.108944 · Cited by 813
The regulation of AMP-activated protein kinase by phosphorylation
STEIN, S. C., Woods, A., Jones, N. A., DAVISON, M. D., & Carling, D. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3450437 · Cited by 605
Research works printed but not linked: 7
- Pederson, 2004, Vol. 2, 202
- Knapper, 1995, J. Nutr., 125, 183
- Trümper, 2001, Mol. Endocrinol., 15, 1559
- Stein, 2000, Biochem. J., 345, 437, 10.1042/bj3450437 · DOI · Paper page
- Kim, 2006, Cell. Signal.
- An, 2005, Am. J. Physiol., 288, E246
- Eckel, 1981, Int. J. Obes., 5, 571
Cited by
Pancreatic regulation of glucose homeostasis.
Röder, P. V., Wu, B., Liu, Y., & Han, W. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.6 · Cited by 985
Coskun, T., Sloop, K. W., Loghin, C., Alsina-Fernandez, J., Urva, S., Bokvist, K. B., Cui, X., Briere, D. A., Cabrera, O., Roell, W. C., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.09.009 · Cited by 882
The role of incretins in glucose homeostasis and diabetes treatment
Kim, W., & Egan, J. M. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.000604 · Cited by 824
“…AMP-activated protein kinase phosphorylation in differentiated 3T3-L1, cultured subcutaneous human adipocytes, and epidermal fat tissue of the VDF Zucker rat (Kim et al., 2007b) and these effects of GIP are mediated through the direct regulation of adipokine resistin release (Kim et al., 2007c).”
BackgroundResultGIP and GLP-1, the two incretin hormones: Similarities and differences
Seino, Y., Fukushima, M., & Yabe, D. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00022.x · Cited by 746
Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
Finan, B., Ma, T., Ottaway, N., Müller, T. D., Habegger, K. M., Heppner, K. M., Kirchner, H., Holland, J., Hembree, J., Raver, C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007218 · Cited by 696
Ge, H., Li, X., Weiszmann, J., Wang, P., Baribault, H., Chen, J.-L., Tian, H., & Li, Y. (2008) · Endocrinology · doi:10.1210/en.2008-0059 · Cited by 475
“The lipase activity was measured using a LPL assay kit according to the manufacturer’s instruction (Roar Biomedicals, New York, NY; RB-LPL2) (12).”
MethodHow May GIP Enhance the Therapeutic Efficacy of GLP-1?
Samms, R. J., Coghlan, M. P., & Sloop, K. W. (2020) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2020.02.006 · Cited by 419
Nauck, M. A., Quast, D. R., Wefers, J., & Pfeiffer, A. F. H. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14496 · Cited by 388
Parker, H. E., Habib, A. M., Rogers, G. J., Gribble, F. M., & Reimann, F. (2009) · Diabetologia · doi:10.1007/s00125-008-1202-x · Cited by 324
“In addition, GIP has been reported to stimulate fat deposition directly in adipocytes and has been postulated to link overnutrition to obesity [3–5].”
Zhang, Q., Delessa, C. T., Augustin, R., Bakhti, M., Colldén, G., Drucker, D. J., Feuchtinger, A., Caceres, C. G., Grandl, G., Harger, A., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.01.015 · Cited by 322
Coskun, T., Urva, S., Roell, W. C., Qu, H., Loghin, C., Moyers, J. S., O’Farrell, L. S., Briere, D. A., Sloop, K. W., Thomas, M. K., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.07.013 · Cited by 316
Hsieh, J., Longuet, C., Baker, C. L., Qin, B., Federico, L. M., Drucker, D. J., & Adeli, K. (2010) · Diabetologia · doi:10.1007/s00125-009-1611-5 · Cited by 275
“Acute administration of GIP reduces circulating chylomicrons, probably by promoting triacylglycerol catabolism by adipose tissue [16, 17]; GLP-1 also attenuates postprandial triacylglycerol secretion [18, 19], although the exact underlying mechanisms are not clear.”
BackgroundSeino, Y., & Yabe, D. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12065 · Cited by 247
McClean, P. L., Irwin, N., Cassidy, R. S., Holst, J. J., Gault, V. A., & Flatt, P. R. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00460.2007 · Cited by 239
Killion, E. A., Wang, J., Yie, J., Shi, S. D.-H., Bates, D., Min, X., Komorowski, R., Hager, T., Deng, L., Atangan, L., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat3392 · Cited by 237
“GIP also directly activates GIPR in adipocytes (10), resulting in fatty acid uptake and incorporation into adipose tissues (11), possibly via lipoprotein lipase (12); promotes glucose uptake, fatty acid synthesis, and fatty acid incorporation into triglycerides; and stimulates lipolysis and subsequent fatty acid reest…”
BackgroundFrias, J. P., Nauck, M. A., Van, J., Benson, C., Bray, R., Cui, X., Milicevic, Z., Urva, S., Haupt, A., & Robins, D. A. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13979 · Cited by 208
“GIP plays an important role in adipose tissue carbohydrate and lipid metabolism by its actions to regulate glucose uptake,(13) lipolysis,(13,14) and lipoprotein lipase activity.(14) In the brain, GIP appears to activate neurons distinct from GLP-1, and intracerebroventricular administration of GIP in mice can inhibit…”
BackgroundKim, S.-J., Nian, C., Karunakaran, S., Clee, S. M., Isales, C. M., & McIntosh, C. H. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040156 · Cited by 182
“tion [14–21].”
BackgroundSelf-citationPower, O., Nongonierma, A. B., Jakeman, P., & FitzGerald, R. J. (2014) · Proceedings of the Nutrition Society · doi:10.1017/s0029665113003601 · Cited by 180
“1), having a direct effect on adipoyctes to promote TAG storage (36) .”
Chapter 15 Glucose‐Dependent Insulinotropic Polypeptide (Gastric Inhibitory Polypeptide; GIP)
McIntosh, C. H. S., Widenmaier, S., & Kim, S. (2009) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)00615-8 · Cited by 171
Self-citationWilson, J. M., Nikooienejad, A., Robins, D. A., Roell, W. C., Riesmeyer, J. S., Haupt, A., Duffin, K. L., Taskinen, M., & Ruotolo, G. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14174 · Cited by 164
“In this study, we also observed a dose-dependent increase in preheparin plasma LPL mass during tirzepatide therapy compared with placebo, in line with previous data, demonstrating that GIP induces LPL activity in vitro and in vivo.(22,23) Notably, GIP enhances the vasodilation and capillary recruitment, resulting in a…”
BackgroundResultAssociation of Pancreatic Fatty Infiltration With Pancreatic Ductal Adenocarcinoma
Hori, M., Takahashi, M., Hiraoka, N., Yamaji, T., Mutoh, M., Ishigamori, R., Furuta, K., Okusaka, T., Shimada, K., Kosuge, T., et al. (2014) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2014.5 · Cited by 160
“In an in vitro setting, it has been shown that glucose-dependent insulinotropic polypeptide activates lipoprotein lipase, leading to TG accumulation in differentiated 3T3-L1 adipocytes in the presence of insulin.(21) Therefore, it is conceivable that induction of high glucose and insulin levels by hyperphagia could be…”
BackgroundMolecular mechanisms underlying nutrient-stimulated incretin secretion
Parker, H. E., Reimann, F., & Gribble, F. M. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s146239940900132x · Cited by 155
Targeting the Incretin/Glucagon System With Triagonists to Treat Diabetes
Capozzi, M. E., DiMarchi, R. D., Tschöp, M. H., Finan, B., & Campbell, J. E. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00117 · Cited by 153
Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes
Tan, Q., Akindehin, S. E., Orsso, C. E., Waldner, R. C., DiMarchi, R. D., Müller, T. D., & Haqq, A. M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.838410 · Cited by 146
Targeting the glucagon receptor family for diabetes and obesity therapy
Cho, Y. M., Merchant, C. E., & Kieffer, T. J. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.05.009 · Cited by 156
Song, D. H., Getty–Kaushik, L., Tseng, E., Simon, J., Corkey, B. E., & Wolfe, M. M. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.09.005 · Cited by 137
Regmi, A., Aihara, E., Christe, M. E., Varga, G., Beyer, T. P., Ruan, X., Beebe, E., O’Farrell, L. S., Bellinger, M. A., Austin, A. K., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.05.010 · Cited by 130
Kim, S.-J., Nian, C., & McIntosh, C. H. S. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m006841 · Cited by 133
Self-citationTargeting the GIPR for obesity: To agonize or antagonize? Potential mechanisms
Campbell, J. E. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101139 · Cited by 133
“In vitro studies describing the adipogenic role of GIP in adipocytes often did so under conditions of supraphysiological insulin concentrations [10,52,53].”
BackgroundHydrogen sulfide reduces serum triglyceride by activating liver autophagy via the AMPK-mTOR pathway
Sun, L., Zhang, S., Yu, C., Pan, Z., Liu, Y., Zhao, J., Wang, X., Yun, F., Zhao, H., Yan, S., et al. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00294.2015 · Cited by 129
Gault, V. A., McClean, P. L., Cassidy, R. S., Irwin, N., & Flatt, P. R. (2007) · Diabetologia · doi:10.1007/s00125-007-0710-4 · Cited by 133
“These mediate various anabolic effects of GIP, including stimulation of glucose uptake, lipoprotein lipase activity, fatty acid synthesis and fatty acid incorporation into adipose tissue [18–21].”
BackgroundTransforming obesity: The advancement of multi-receptor drugs
Kusminski, C. M., Perez-Tilve, D., Müller, T. D., DiMarchi, R. D., Tschöp, M. H., & Scherer, P. E. (2024) · Cell · doi:10.1016/j.cell.2024.06.003 · Cited by 126
Phillips, L. K., & Prins, J. B. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06491.x · Cited by 119
Kim, S.-J., Nian, C., & McIntosh, C. H. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704896200 · Cited by 118
Self-citationIncretin Hormones and Type 2 Diabetes—Mechanistic Insights and Therapeutic Approaches
Boer, G. A., & Holst, J. J. (2020) · Biology · doi:10.3390/biology9120473 · Cited by 153
Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance
Ceperuelo-Mallafré, V., Duran, X., Pachón, G., Roche, K., Garrido-Sánchez, L., Vilarrasa, N., Tinahones, F. J., Vicente, V., Pujol, J., Vendrell, J., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3350 · Cited by 112
“Reconciling these differences is challenging, although most studies that examine GIP use comparable in vitro conditions (17, 36, 37), and little is known regarding the in vivo actions of GIP in human adipose tissue.”
BackgroundIs adipose tissue metabolically different at different sites?
Gil, A., Olza, J., Gil-Campos, M., Gomez-Llorente, C., & Aguilera, C. M. (2011) · International Journal of Pediatric Obesity · doi:10.3109/17477166.2011.604326 · Cited by 115
Dynamics of fat absorption and effect of sham feeding on postprandial lipema
Chavez–Jauregui, R. N., Mattes, R. D., & Parks, E. J. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.05.002 · Cited by 109
Godinho, R., Mega, C., Teixeira-de-Lemos, E., Carvalho, E., Teixeira, F., Fernandes, R., & Reis, F. (2015) · Journal of Diabetes Research · doi:10.1155/2015/806979 · Cited by 109
“While GLP-1R is expressed in adipocytes [57], activation of GLP-1R affects none of the aforementioned signaling molecules and does not increase LPL activity in adipocytes [58, 59].”
BackgroundWidenmaier, S. B., Kim, S.-J., Yang, G. K., De Los Reyes, T., Nian, C., Asadi, A., Seino, Y., Kieffer, T. J., Kwok, Y. N., & McIntosh, C. H. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009590 · Cited by 102
“3T3-L1 cells were cultured onto 96-well culture plates and induced to differentiate into adipocytes as previously described [37].”
MethodSelf-citationGabe, M. B. N., Sparre‐Ulrich, A. H., Pedersen, M. F., Gasbjerg, L. S., Inoue, A., Bräuner‐Osborne, H., Hartmann, B., & ROSENKILDE, M. M. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.01.040 · Cited by 96
Joo, E., Harada, N., Yamane, S., Fukushima, T., Taura, D., Iwasaki, K., Sankoda, A., Shibue, K., Harada, T., Suzuki, K., et al. (2017) · Diabetes · doi:10.2337/db16-0758 · Cited by 96
Gögebakan, Ö., Osterhoff, M. A., Schüler, R., Pivovarova, O., Kruse, M., Seltmann, A.-C., Mosig, A. S., Rudovich, N., Nauck, M., & Pfeiffer, A. F. H. (2015) · Diabetologia · doi:10.1007/s00125-015-3618-4 · Cited by 95
“GIPRs are known to be present on adipocytes and were shown to play a role in the regulation of glucose and lipid metabolism as well as in adipocyte differentiation [20–23].”
Abu‐Farha, M., Ghosh, A., Al‐Khairi, I., Madiraju, S. R. M., Abubaker, J. A., & Prentki, M. (2020) · Progress in Lipid Research · doi:10.1016/j.plipres.2020.101067 · Cited by 97
Glucose-dependent insulinotropic polypeptide (GIP)
Müller, T. D., Adriaenssens, A. E., Ahrén, B., Blüher, M., Birkenfeld, A. L., Campbell, J. E., Coghlan, M. P., D’Alessio, D. D., Deacon, C. F., DelPrato, S., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102118 · Cited by 112
Varol, C., Zvibel, I., Spektor, L., Mantelmacher, F. D., Vugman, M., Thurm, T., Khatib, M., Elmaliah, E., Halpern, Z., & Fishman, S. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401149 · Cited by 89
Zhu, Q., Ghoshal, S., Rodrigues, A., Gao, S., Asterian, A., Kamenecka, T. M., Barrow, J. C., & Chakraborty, A. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85510 · Cited by 87
“Expression of endogenous AMPKα1 and α2 isoforms was diminished by introducing a pool of 3 siRNAs targeting AMPKα (92).”
BackgroundTimper, K., Grisouard, J., Sauter, N. S., Herzog-Radimerski, T., Dembinski, K., Peterli, R., Frey, D. M., Zulewski, H., Keller, U., Müller, B., et al. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00100.2012 · Cited by 88
“Depending on experimental conditions in vitro, GIP also influences lipid metabolism in rodent (64) and human adipocytes (61) via lipogenesis (36) and lipolyis (22, 25, 38).”
BackgroundWei, X., Wang, D., Yang, Y., Xia, M., Li, D., Li, G., Zhu, Y., Xiao, Y., & Ling, W. (2011) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.4275 · Cited by 89
Hutchinson, D. S., Summers, R. J., & Bengtsson, T. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.05.008 · Cited by 99
Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents
Gasbjerg, L. S., Gabe, M. B. N., Hartmann, B., Christensen, M. B., Knop, F. K., Holst, J. J., & Rosenkilde, M. M. (2018) · Peptides · doi:10.1016/j.peptides.2017.11.021 · Cited by 85
Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism
Trzaskalski, N. A., Fadzeyeva, E., & Mulvihill, E. E. (2020) · Clinical Medicine Insights: Endocrinology and Diabetes · doi:10.1177/1179551420912972 · Cited by 85
Porter, D. W., Irwin, N., Flatt, P. R., Hölscher, C., & Gault, V. A. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.10.059 · Cited by 93
“Furthermore, since GIP has various anabolic effects on adipocytes (Eckel et al., 1979; Oben et al., 1991; Kim et al., 2007) and ablation of GIP receptor signalling has been shown to prevent or reverse weight gain (Irwin and Flatt, 2009), lack of observable effects on body weight is encouraging in terms of a potential…”
BackgroundChen, S., Okahara, F., Osaki, N., & Shimotoyodome, A. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00418.2014 · Cited by 81
“GIPR is also located in adipose tissue (38) and contributes to energy storage as fat in adipocytes (16).”
BackgroundThondam, S. K., Cuthbertson, D. J., & Wilding, J. P. H. (2020) · Peptides · doi:10.1016/j.peptides.2019.170208 · Cited by 77
Recent Updates on Obesity Treatments: Available Drugs and Future Directions
Dragano, N. R. V., Fernø, J., Diéguez, C., López, M., & Milbank, E. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.04.034 · Cited by 84
Thondam, S. K., Daousi, C., Wilding, J. P. H., Holst, J. J., Ameen, G. I., Yang, C., Whitmore, C., Mora, S., & Cuthbertson, D. J. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00347.2016 · Cited by 71
“expression/activity (a lipogenic enzyme) (15, 26) or by reduc-”
Girard, J. R. (2008) · Diabetes & Metabolism · doi:10.1016/j.diabet.2008.09.001 · Cited by 85
GIP regulates inflammation and body weight by restraining myeloid-cell-derived S100A8/A9
Mantelmacher, F. D., Zvibel, I., Cohen, K., Epshtein, A., Pasmanik-Chor, M., Vogl, T., Kuperman, Y., Weiss, S., Drucker, D. J., Varol, C., et al. (2018) · Nature Metabolism · doi:10.1038/s42255-018-0001-z · Cited by 70
GIPR Is Predominantly Localized to Nonadipocyte Cell Types Within White Adipose Tissue
Campbell, J. E., Beaudry, J. L., Svendsen, B., Baggio, L. L., Gordon, A. N., Ussher, J. R., Wong, C. K., Gribble, F. M., D’Alessio, D. A., Reimann, F., et al. (2022) · Diabetes · doi:10.2337/db21-1166 · Cited by 68
Resistin affects lipid metabolism during adipocyte maturation of 3T3‐L1 cells
Ikeda, Y., Tsuchiya, H., Hama, S., Kajimoto, K., & Kogure, K. (2013) · FEBS Journal · doi:10.1111/febs.12514 · Cited by 73
Sensing Via Intestinal Sweet Taste Pathways
Young, R. L. (2011) · Frontiers in Neuroscience · doi:10.3389/fnins.2011.00023 · Cited by 69
“…released postprandially in proportion to calorific load (Pilichiewicz et al., 2007), and acts to stimulate insulin release and to promote lipid storage in adipocytes, the latter an emerging role that may link overnutrition to obesity (Yip et al., 1998; Baggio and Drucker, 2007; Kim et al., 2007).”
BackgroundGlucose-dependent insulinotropic polypeptide (GIP) and cardiovascular disease
Heimbürger, S. M., Bergmann, N. C., Augustin, R., Gasbjerg, L. S., Christensen, M. B., & Knop, F. K. (2020) · Peptides · doi:10.1016/j.peptides.2019.170174 · Cited by 67
Differential processing of pro-glucose-dependent insulinotropic polypeptide in gut
Fujita, Y., Asadi, A., Yang, G. K., Kwok, Y. N., & Kieffer, T. J. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00024.2010 · Cited by 66
Weaver, R. E., Donnelly, D., Wabitsch, M., Grant, P. J., & Balmforth, A. J. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.148 · Cited by 63
Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes
Gutgesell, R. M., Nogueiras, R., Tschöp, M. H., & Müller, T. D. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01566-x · Cited by 61
“Apart from stimulating the secretion of either insulin or glucagon in glucose-dependent manner [33], GIP promotes lipogenesis and lipid deposition under conditions of hyperin-sulinema [34–36] while stimulating lipolysis and fatty acid oxidation under conditions of normo-or hypoinsulinemia [37–39].”
BackgroundMolecular mechanisms underlying nutrient detection by incretin-secreting cells
Reimann, F. (2010) · International Dairy Journal · doi:10.1016/j.idairyj.2009.11.014 · Cited by 61
Martinou, E., Stefanova, I., Iosif, E., & Angelidi, A. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063339 · Cited by 69
“In addition, GIP promotes triglycerides storage in the adipocytes through the stimulation of lipoprotein lipase [237].”
BackgroundKwon, E., Lee, J., Kim, Y.-S., Do, A., Choi, J., Cho, S.-J., Jung, U. J., Lee, M., Park, Y., & Choi, M. (2017) · Nutrients · doi:10.3390/nu9060569 · Cited by 65
“Additionally, recent studies demonstrated that the binding of GIP to GIPR in the 3T3-L1 cells and adipose tissue of rats results in the increased secretion of resistin, and thus, GIP activates phosphoinositide 3-kinase (PI3K) and Akt/PKB (protein kinase B) through secreted resistin, thereby suppressing AMP-activated p…”
BackgroundMohammad, S., Ramos, L. S., Buck, J., Levin, L. R., Rubino, F., & McGraw, T. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.289009 · Cited by 59
Kim, S.-J., Nian, C., & McIntosh, C. H. S. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m012203 · Cited by 58
Self-citationGlucose‐dependent insulinotropic polypeptide signaling in pancreatic β‐cells and adipocytes
McIntosh, C. H., Widenmaier, S., & Kim, S. (2012) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2012.00196.x · Cited by 57
Self-citationEffect of tirzepatide on blood pressure and lipids: a meta-analysis of randomized controlled trials
Kanbay, M., Copur, S., Siriopol, D., Yildiz, A. B., Gaipov, A., van Raalte, D. H., & Tuttle, K. R. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15272 · Cited by 56
“CI , confidence interval; SD, standard deviation. cholesterols, 28,29 inducing differentiation of pre-adipocytes into adipocytes through transcription factors, 30 and increasing peripheral insulin sensitivity.”
BackgroundDiabetes and obesity treatment based on dual incretin receptor activation: ‘twincretins’
Skow, M. A., Bergmann, N. C., & Knop, F. K. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12685 · Cited by 56
“In vitro, GIP has been shown to cause a dose-dependent increase of lipoprotein lipase activity and accumulation of fatty acids in cultured human adipocytes and in differentiated 3T3-L1 cells [22].”
BackgroundZhou, Q., Lei, X., Fu, S., Liu, P., Long, C., Wang, Y., Li, Z., Xie, Q., & Chen, Q. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01198-4 · Cited by 55
“…GIP is implicated in adipose tissue mass and metabolism by regulating glucose uptake [41], lipolysis [42], and the activity of lipoprotein lipases [43, 44], some of which suggest the adipogenic effect of GIP with studies indicating GIPR knockout mice and chronic elevation of serum GIP levels in a…”
BackgroundNie, Y., Ma, R. C., Chan, J. C. N., Xu, H., & Xu, G. (2012) · The FASEB Journal · doi:10.1096/fj.11-196782 · Cited by 53
Sayari, S., Neishaboori, H., & Jameshorani, M. (2018) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2018.0006 · Cited by 55
“How sitagliptin improves lipid profile is not well known, but it is said that gastric inhibitory polypeptide (GIP) can purify the circulating chylomicrons by stimulating the activity of adipose tissue lipoprotein lipase.(33,34) On the other hand, GLP-1 can decrease the secretion of triacylglycerol after meal.”
BackgroundCeddia, R. P., & Collins, S. (2020) · Clinical Science · doi:10.1042/cs20190579 · Cited by 53
Zhao, F., Zhang, C., Zhou, Q., Hang, K., Zou, X., Chen, Y., Wu, F., Rao, Q., Dai, A., Yin, W., et al. (2021) · eLife · doi:10.7554/elife.68719 · Cited by 49
“In response to food intake, GIP is secreted by intestinal K cells to enhance insulin secretion and peripheral fatty acid uptake (Kim et al., 2007), as well as a number of neuronal effects (Faivre and Hölscher, 2013).”
BackgroundPercy, C., Brown, L., Power, D. A., Johnson, D. W., & Gobe, G. C. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.10.003 · Cited by 49
“In a separate study, increased phosphorylation of Akt/PKB was linked to triglyceride and lipoprotein lipase activity, and reductions in phosphorylation of AMPK, in the presence of insulin (Kim et al., 2007).”
Ugleholdt, R., Pedersen, J., Bassi, M. R., Füchtbauer, E.-M., Jørgensen, S. M., Kissow, H.-L., Nytofte, N., Poulsen, S. S., Rosenkilde, M. M., Seino, Y., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.311779 · Cited by 49
Nutrition and l and K-enteroendocrine cells
Gutierrez-Aguilar, R., & Woods, S. C. (2011) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32834190b5 · Cited by 47
Intestinal Adaptations after Bariatric Surgery: Consequences on Glucose Homeostasis
Cavin, J., Bado, A., & Gall, M. L. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.01.002 · Cited by 52
Yamada, C., Yamada, Y., Tsukiyama, K., Yamada, K., Yamane, S., Harada, N., Miyawaki, K., Seino, Y., & Inagaki, N. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.09.128 · Cited by 47
Peripheral neural targets in obesity
Page, A. J., Symonds, E., Peiris, M., Blackshaw, L. A., & Young, R. L. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01951.x · Cited by 43
“…released postprandially in proportion to calorific load (Pilichiewicz et al., 2007a), and acts to stimulate insulin release and promote lipid storage in adipocytes, the latter an emerging role that may link overnutrition to obesity (Yip et al., 1998; Baggio and Drucker, 2007; Kim et al., 2007).”
BackgroundIrwin, N., McClean, P. L., Patterson, S., Hunter, K., & Flatt, P. R. (2009) · bchm · doi:10.1515/bc.2009.002 · Cited by 41
Pleiotropic Actions of the Incretin Hormones
McIntosh, C. H. S., Widenmaier, S. B., & Kim, S. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00002-3 · Cited by 46
Self-citationInsights into incretin-based therapies for treatment of diabetic dyslipidemia
Stemmer, K., Finan, B., DiMarchi, R. D., Tschöp, M. H., & Müller, T. D. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.05.008 · Cited by 43
Boer, G. A., Keenan, S. N., Miotto, P. M., Holst, J. J., & Watt, M. J. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00646.2020 · Cited by 38
Shimotoyodome, A., Fukuoka, D., Suzuki, J. S., Fujii, Y., Mizuno, T., Meguro, S., Tokimitsu, I., & Hase, T. (2009) · Endocrinology · doi:10.1210/en.2008-1162 · Cited by 37
Gabe, M. B. N., van der Velden, W. J. C., Smit, F. X., Gasbjerg, L. S., & Rosenkilde, M. M. (2020) · Peptides · doi:10.1016/j.peptides.2019.170224 · Cited by 37
GIP’s involvement in the pathophysiology of type 2 diabetes
Christensen, M. B., Gasbjerg, L. S., Heimbürger, S. M., Stensen, S., Vilsbøll, T., & Knop, F. K. (2020) · Peptides · doi:10.1016/j.peptides.2019.170178 · Cited by 35
Novel GLP-1-based Medications for Type 2 Diabetes and Obesity
Son, J. W., le Roux, C. W., Blüher, M., Nauck, M. A., & Lim, S. (2026) · Endocrine Reviews · doi:10.1210/endrev/bnaf036 · Cited by 40
Baldassano, S., Gasbjerg, L. S., Kizilkaya, H. S., ROSENKILDE, M. M., Holst, J. J., & Hartmann, B. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00492 · Cited by 34
Dekker, M. J., Graham, T. E., Ooi, T. C., & Robinson, L. E. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.08.004 · Cited by 32
Paschetta, E., Hvalryg, M., & Musso, G. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00897.x · Cited by 32
Lee, S., Yang, K. J. Z., Brun, P., Silvaroli, J. A., Yuen, J. J., Shmarakov, I. O., Jiang, H., FERANIL, J. B., Li, X., Lackey, A. I., et al. (2020) · Science Advances · doi:10.1126/sciadv.aay8937 · Cited by 35
“GIP is reported to exert direct effects on adipocytes including the enhancement of lipoprotein lipase transcription and activity facilitating fatty acid uptake from the postprandial circulation by adipocytes and the suppression of intra-cellular lipolysis ( 48 , 49 ).”
Yamada, Y., Terauchi, Y., Watada, H., Nakatsuka, Y., Shiosakai, K., Washio, T., & Taguchi, T. (2018) · Advances in Therapy · doi:10.1007/s12325-018-0668-2 · Cited by 32
van Thuijl, H., Kola, B., & Korbonits, M. (2007) · Vitamins and hormones · doi:10.1016/s0083-6729(06)77006-6 · Cited by 34
Distribution and Stimulus Secretion Coupling of Enteroendocrine Cells along the Intestinal Tract
Adriaenssens, A. E., Reimann, F., & Gribble, F. M. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170047 · Cited by 41
Metadata
- Authors
- Kim, S.-J., Nian, C., & McIntosh, C. H. S.
- Affiliations
- University of British Columbia (CA)
- Corresponding author
- McIntosh, Christopher H.S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-03
- Volume
- 282
- Issue
- 12
- Pages
- 8557-8567
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2079889142
- Cited by
- 216
- References
- 56
- Citations by year
- 2026: 10 · 2025: 14 · 2024: 18 · 2023: 12 · 2022: 7 · 2021: 8 · 2020: 17 · 2019: 13 · 2018: 13 · 2017: 11 · 2016: 5 · 2015: 5 · 2014: 7 · 2013: 9 · 2012: 10
- FWCI
- 9.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4964 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- glucose-dependent insulinotropic polypeptide, lipoprotein lipase, adipocytes, triglyceride accumulation, Akt, LKB1, AMPK, AMPK inhibition, glucagon-like peptide-1, fat metabolism, signal transduction, 3T3-L1 adipocytes, epididymal adipose tissue
- MeSH terms
- AMP-Activated Protein Kinase Kinases, Animals, Enzyme Activation, Gastric Inhibitory Polypeptide, Glucose, Humans, Lipoprotein Lipase, Multienzyme Complexes, Rats, Zucker, Protein Serine-Threonine Kinases, Adipocytes, 3T3-L1 Cells, Proto-Oncogene Proteins c-akt, Mice, Rats, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.